Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Botanix Pharmaceuticals Limited ( (AU:BOT) ) just unveiled an announcement.
Botanix Pharmaceuticals has completed its security purchase plan, issuing 14,341,646 new shares at A$0.06 to raise A$860,500, alongside one-for-one options, while the underwritten shortfall of A$4,139,500 will be taken up by joint lead managers and sub-underwriters. Combined with a previously announced A$40 million placement, the company has secured a total of A$45 million before costs, earmarked for API purchases and manufacturing, setting up an alternative API supplier, advertising and marketing, operating expenses, working capital, and capital-raising costs.
New securities under the SPP, including the shortfall allocations and sub-underwriter options, plus options tied to the placement approved by shareholders on 1 April 2026, are scheduled to be issued on 20 April 2026, with trading of the new shares on the ASX expected to commence on 21 April 2026. The successful completion of this capital raising bolsters Botanix’s funding base as it moves to commercialize Sofdra and expand its dermatology operations, potentially strengthening its market position in the emerging hyperhidrosis treatment segment.
The most recent analyst rating on (AU:BOT) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Botanix Pharmaceuticals Limited stock, see the AU:BOT Stock Forecast page.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited is a commercial dermatology company based in Philadelphia and Phoenix, focused on treatments for skin disorders. Its lead product, Sofdra, recently received FDA approval as the first and only new chemical entity indicated for primary axillary hyperhidrosis, addressing an underserved market for patients with excessive underarm sweating.
Average Trading Volume: 15,652,456
Technical Sentiment Signal: Sell
Current Market Cap: A$94.92M
See more data about BOT stock on TipRanks’ Stock Analysis page.